Active Ingredient(s): Fosamprenavir
FDA Approved: * October 20, 2003
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lexiva Overview

Fosamprenavir (marketed by ViiV Healthcare as the calcium salt under the trade names Lexiva in the U.S. and Telzir in Europe) is a drug for the treatment of HIV infections. It is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir. The FDA approved it October 20, 2003, while the EMA approved it on July 12, 2004. The human body metabolizes fosamprenavir in order to form amprenavir, which is the active ingredient. That metabolization increases the duration that amprenavir is...

Read more Lexiva Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fosamprenavir

Recent Lexiva Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Suspension: 50mg base/ml, 50mg/ml
  • Tablet: 700mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lexiva: (6 results)

Sorted by National Drug Code
  • 49349-811 Lexiva 700 mg Oral Tablet by Remedyrepack Inc.
  • 49702-207 Lexiva 700 mg Oral Tablet by Viiv Healthcare Company
  • 49702-208 Lexiva 50 mg/ml Oral Suspension by Viiv Healthcare Company
  • 53808-0281 Lexiva 700 mg Oral Tablet by State of Florida Doh Central Pharmacy
  • 53808-1010 Lexiva 700 mg Oral Tablet, Film Coated by State of Florida Doh Central Pharmacy
  • 69189-0210 Lexiva 700 mg Oral Tablet, Film Coated by Avera Mckennan Hospital

Other drugs which contain Fosamprenavir or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA